Seattle, WA, United States of America

Mohammed Shoyab


Average Co-Inventor Count = 3.0

ph-index = 8

Forward Citations = 210(Granted Patents)


Company Filing History:


Years Active: 1987-1999

Loading Chart...
20 patents (USPTO):Explore Patents

Title: Mohammed Shoyab: Innovator in Growth Regulatory Proteins

Introduction

Mohammed Shoyab is a prominent inventor based in Seattle, WA, known for his significant contributions to biotechnology through his extensive research and innovation in the field of growth regulatory proteins. With a portfolio of 20 patents, Shoyab has established himself as a leading figure in the scientific community.

Latest Patents

Shoyab's latest patents reflect his groundbreaking work in the synthesis and application of growth regulatory proteins. His patent on DNA encoding epithelins introduces a novel family of proteins known as 'epithelins', which consist of several members that share structural homology. Notably, epithelin 1 is identified as a bifunctional growth regulator, stimulating some cell types while inhibiting others, whereas epithelin 2 provides similar inhibitory effects without the stimulatory capability of its counterpart. Additionally, Shoyab has developed monoclonal antibodies targeting Oncostatin M, a newly characterized cytokine. These antibodies are pivotal in detecting Oncostatin M, inhibiting its receptor binding, and modulating its bioactivities in various systems, showcasing the potential for therapeutic applications.

Career Highlights

Shoyab has had a fruitful career with notable associations at companies such as Oncogen and Bristol-Myers Squibb, where he advanced his research initiatives and contributed to the field of biotechnology through various innovative projects. His work has significantly impacted the understanding and utilization of cytokines and growth regulatory proteins in therapeutic interventions.

Collaborations

Throughout his career, Shoyab has collaborated with esteemed scientists, including Hans Marquardt and George J. Todaro. These partnerships have been instrumental in furthering research and development in the biotechnology sector, leading to advancements in the understanding of protein interactions and their biological significance.

Conclusion

In summary, Mohammed Shoyab's pioneering research and innovative patents underscore his role as a key inventor in the biotechnology industry. His contributions to the understanding of epithelins and Oncostatin M highlight the importance of his work in developing therapeutic strategies and advancing scientific knowledge in growth regulation. Shoyab's legacy continues to inspire future innovations in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…